Patent application number | Description | Published |
20100072060 | Biomedical Electrode and Method of Formation Thereof - The present disclosure relates to biomedical electrodes incorporating hydrophobic material and methods of formation thereof. | 03-25-2010 |
20100075532 | Fluorescent Marker for Detecting Gel or Lack of Gel - A conductive composition having a transparent and colorless appearance under normal or ambient lighting and at least a dyed, translucent or fluorescent appearance under artificial lighting is provided. The composition includes a photo-reactive quantity of a dye-marker. | 03-25-2010 |
20100076294 | System and Method of Prepping Skin Prior to Electrode Application - An electrode is provided that includes a conductive member defining a first side and a second side; a conductive composition disposed on the first side of the conductive member, wherein the conductive composition includes a therapeutically effective quantity of an exfoliant; and an electrical lead in electrical communication with the conductive member. The conductive composition is capable of reducing a level of an impedance of the skin of the subject. | 03-25-2010 |
20110230816 | Gels for Transdermal Delivery - The present disclosure provides hydrogels that are suitable for drug delivery. In embodiments, hydrogels of the present disclosure may be used for transdermal delivery of bioactive agents, including drugs. The hydrogels of the present disclosure may also be useful as conductive compositions for use with electrodes. | 09-22-2011 |
20110230925 | Electrode Delivery System - According to an aspect of the present disclosure, an automatic external defibrillator configured to deliver electrical pulses and/or shocks to a heart of a patient during a cardiac emergency is provided and includes a housing supporting an electrical connector; a defibrillator electrode delivery system supported on the housing; and a pair of defibrillation electrode pads supported by the defibrillator electrode delivery system. Each of the pair of defibrillation electrode pads is pre-connected to the electrical connector of the housing. A hydrogel layer of each defibrillation electrode pad is retained by the defibrillator electrode delivery system in such a manner so as to reduce a moisture vapor transmission rate thereof. | 09-22-2011 |
20130071450 | GELS FOR TRANSDERMAL DELIVERY - The present disclosure provides hydrogels that are suitable for drug delivery. In embodiments, hydrogels of the present disclosure may be used for transdermal delivery of bioactive agents, including drugs. The hydrogels of the present disclosure may also be useful as conductive compositions for use with electrodes. | 03-21-2013 |
20130289689 | ELECTRODE DELIVERY SYSTEM - An automatic external defibrillator configured to deliver electrical pulses and/or shocks to a heart of a patient during a cardiac emergency includes a housing supporting an electrical connector; a defibrillator electrode delivery system supported on the housing and a pair of defibrillation electrode pads supported by the defibrillator electrode delivery system. Each of the pair of defibrillation electrode pads is pre-connected to the electrical connector of the housing. A hydrogel layer of each defibrillation electrode pad is retained by the defibrillator electrode delivery system in such a manner so as to reduce a moisture vapor transmission rate thereof. | 10-31-2013 |
20140173871 | MEDICAL ELECTRODE INCLUDING FLUORESCENT MARKER - A conductive composition having a transparent and colorless appearance under normal or ambient lighting and at least a dyed, translucent or fluorescent appearance under artificial lighting is provided. The composition includes a photo-reactive quantity of a dye-marker. | 06-26-2014 |
20140296826 | PREPARATION PATCH AND SAFETY SYRINGE SYSTEM - A safety syringe system including a safety syringe and an injection site preparation patch adapted for use with the safety syringe. The safety syringe includes a syringe body and a safety shield slidably disposed about the syringe body. The injection site preparation patch has a tissue-facing side and a syringe-facing side, and may include a substrate, a syringe adhesive layer adapted to adhere to a distal flange of the safety shield, a hydrogel layer adapted to adhere to tissue, and removable release liners disposed on either side. The patch may include a medicament, anesthetic, or a thermal compound. Adhesion between the patch and the flange is less than adhesion between the patch and tissue, so that the patch adheres to the shield with sufficient strength to enable the shield to slide over the needle upon withdrawal, but with insufficient strength to cause the patch to pull away from a patient's skin. | 10-02-2014 |